{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Peptide Show","title":"Dr Edwin Lee: Do you know peptides better than your doctor?","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/5f66adf4\"></iframe>","width":"100%","height":180,"duration":1689,"description":"Ten peptide vials in a Ziploc bag. No labels. \n\nOne of Dr Edwin Lee’s sons took the photo at college. The vials belonged to his roommate, who was into peptides. There was no way to tell what was in them. At a swimming pool, a 22-year-old lifeguard told Edwin he was using peptides too. Edwin reckoned the lifeguard knew more about them than many doctors. \nEdwin is an endocrinologist and co-founder of the Clinical Peptide Society, where he teaches clinicians about peptides. \nHe joins Richard Skaife to talk about what patients are already trying, what doctors are being asked to prescribe, and what happens when someone has a side effect and nobody records it. \nHe explains\n\n■ What a “yes” from FDA advisers means for peptides such as BPC-157 and Epitalon\n■ Why he wants a registry that makes peptide side effects visible\n■ Why he starts with sleep, nutrition, and hormones before introducing peptides in his own practice\n■ What he’d want a larger human trial to answer about SS-31 and diabetic kidney disease\n■ How he’d test BPC-157 and thymosin beta 4 for knee injuries to see whether either works alone, whether the combination works better, or whether placebo tells a different story\nChapters\n\n\n\nFurther reading\n\nFDA. The July 2026 advisory meeting materials name the seven peptide groups under consideration and the uses the FDA reviewed for each. Read the FDA meeting materials\n\nDinetz and Lee. Edwin co-authored a narrative review of human studies on thymosin alpha 1, the peptide he discusses from an earlier FDA advisory meeting. Read the review on PubMed\n\nFDA MedWatch. The FDA’s existing reporting program accepts reports from patients and health professionals about suspected serious reactions and product quality problems. See how MedWatch works\n\n\nFollow Dr Edwin Lee\n\nClinical Peptide Society: Edwin Lee’s profile\n\nFollow Richard Skaife\n\nLinkedIn: linkedin.com/in/richardskaife/\n\nPeptide Show\n\nWebsite: Peptide.Show\nInstagram: @Peptide.Show\nTikTok: @peptide.show\nFacebook: Peptide...","thumbnail_url":"https://img.transistorcdn.com/QcXtaDr9qe6jHT4c0BxQri4VufvdedcvMTMLmbuyqSA/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZTg2/YmYyODMzN2NhMDNh/NzMzZGUxMzJhNDFj/YjVmMS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}